The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.
|Number of pages||15|
|State||Published - Jun 19 2014|
- Acute coronary syndrome
- Myocardial infarction
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine